Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Intended for healthcare professionals
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Archive
Search for this keyword
Advanced search
Close
More
Main menu
Archive
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
Archive
Volume 83, Issue 2
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Vasculitis
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial
Online download statistics by month:
Online download statistics by month: November 2023 to April 2025
Abstract
Full
Pdf
Nov 2023
1260
1199
553
Dec 2023
966
939
445
Jan 2024
1505
1495
590
Feb 2024
975
936
486
Mar 2024
960
949
435
Apr 2024
873
876
377
May 2024
736
730
348
Jun 2024
759
749
388
Jul 2024
821
814
298
Aug 2024
876
869
250
Sep 2024
662
656
219
Oct 2024
926
907
330
Nov 2024
861
863
347
Dec 2024
844
823
280
Jan 2025
725
733
187
Feb 2025
608
616
144
Mar 2025
492
499
135
Apr 2025
466
467
123
Total
15315
15120
5935
Read the full text or download the PDF:
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?